Abstract
ObjectivesClinical trials of new therapeutics are typically evaluated against the primary disease symptom with limited consideration of secondary effects be they positive or negative. Desirability of outcome ranking (DOOR) is...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
